Adherence to chronic opioid therapy prescribing guidelines in a primary care clinic

Cynthia Kay, MD, MS; Erica Wozniak, MS; Sarah Koller, DO; Audrey Ye, MD; Joanne Bernstein, MD

doi:10.5055/jom.2016.0350

Authors

Cynthia Kay, MD, MS
Erica Wozniak, MS
Sarah Koller, DO
Audrey Ye, MD
Joanne Bernstein, MD

DOI:

https://doi.org/10.5055/jom.2016.0350

Keywords:

chronic pain, opioids, primary care

Abstract

Objective: Characterize primary care patients prescribed opioids for chronic noncancer pain (CNCP), explore guideline-recommended opioid-monitoring practices, and investigate predictors of pain agreements.

Design: Retrospective chart review.

Setting: Primary care clinic at a tertiary academic medical center.

Patients: Adults prescribed chronic opioids (three or more monthly prescriptions within a year) for CNCP between April 1, 2014 and April 1, 2015. Patients without CNCP served as controls.

Main Outcome Measure: Patient demographics, medical diagnoses, tobacco status, provider status, documentation of guideline-recommended opioid-monitoring practices, pain agreement status, and opioid prescription. Univariate statistics were used to explore differences in patient demographics, comorbidities, and guideline-recommended opioid-monitoring practices by chronic pain and pain agreement status. Logistic regression was used to investigate predictors of agreement status.

Results: The clinic had 834 (9 percent) patients on chronic opioids, with 335 on a pain agreement. Documentation of opioid-monitoring practices was lacking. Logistic regression indicated that patients were significantly more likely to be on an agreement if they were Caucasian (adjusted odds ratio [OR] 2.17 [95% CI 1.41, 3.39]), had a baseline urine drug screen (adjusted OR 10.72 [95% CI 6.16, 19.41]), were prescribed a schedule II controlled medication (adjusted OR 11.92 [95% CI 6.93, 21.62]), and had risk assessed to some degree (adjusted OR 3.06 [95% CI 1.90, 4.96]).

Conclusions: Aside from race, most patient characteristics were not predictive of pain agreement implementation. However, controlled medication of higher schedules and the use of certain guideline-recommended practices were associated with an agreement. Studies are needed to examine whether pain agreement or guideline-adherence influence clinical outcomes.

Author Biographies

Cynthia Kay, MD, MS

Clement J Zablocki VA Medical Center, Milwaukee, Wisconsin; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for Patient Care and Outcomes Research, Medical College of Wisconsin, Milwaukee, Wisconsin

Erica Wozniak, MS

Center for Patient Care and Outcomes Research, Medical College of Wisconsin, Milwaukee, Wisconsin.

Sarah Koller, DO

Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin

Audrey Ye, MD

Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin

Joanne Bernstein, MD

Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin

References

Volkow ND: American's addiction to opioids: Heroin and prescription drug abuse. Bethesda, MD: National Institute on Drug Abuse, 2014. Available at http://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2014/americas-addiction-to-opioids-heroin-prescription-drug-abuse. Accessed November 14, 2015.

Franklin G: Opioids for chronic noncancer pain: A position paper of the American academy of neurology. Neurology. 2014; 83(14): 1277-1284.

Gounder C: Who is responsible for the pain-pill epidemic? The New Yorker. 2013. http://www.newyorker.com/business/currency/who-is-responsible-for-the-pain-pill-epidemic. Accessed May 24, 2016.

American Pain Society (USA): Assessment of Pain, United States. Chicago, IL: American Pain Society, 2016. Available at http://americanpainsociety.org/uploads/education/section_2.pdf. Accessed May 24, 2016.

Mularski RA, White-Chu F, Overbay D, et al.: Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med. 2006; 21(6): 607-612.

Van Zee A: The promotion and marketing of oxycontin: Commercial triumph, public health tragedy. Am J Public Health. 2009; 99(2): 221-227.

Paulozzi LJ, Jones CM, Mack KA, et al.: Vitals signs: Overdoses of prescription opioid pain relievers—United States, 1998-2008. Atlanta, GA: Centers for Disease Control and Prevention, 2011. Available at http://www.cdc.gov/mmwr/pdf/wk/mm6043.pdf. Accessed November 14, 2015.

Centers for Disease Control and Prevention (USA): Prescription painkiller overdoses. Atlanta, GA: Centers for Disease Control and Prevention, 2013. Available at http://www.cdc.gov/vitalsigns/PrescriptionPainkillerOverdoses/index.html. Accessed November 14, 2015.

Consumer Reports: The dangers of painkillers: A special report. 2014. Available at http://www.consumerreports.org/cro/magazine/2014/09/the-dangers-of-painkillers/index.htm. Accessed November 14, 2015.

Cheatle MD, Barker C: Improving opioid prescription practices and reducing patient risk in the primary care setting. J Pain Res. 2014; 7: 301-311.

Prescription Drug Monitoring Program Training and Technical Assistance Center: Prescription drug monitoring frequently asked questions (FAQ). Available at http://www.pdmpassist.org/content/prescription-drug-monitoring-frequentlyasked-questions-faq. Accessed November 14, 2015.

Chou R, Fanciullo GJ, Fine PG, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10(2): 113-130.

Butler SF, Fernandez K, Benoit C, et al.: Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008; 9(4): 360-372.

Moore TM, Jones T, Browder JH, et al.: A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med. 2009; 10(8): 1426-1433.

Chou R, Fanciullo GJ, Fine PG, et al.: Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009; 10(2): 131-146.

Sauver JL, Warner DO, Yawn BP, et al.: Why patients visit their doctors: Assessing the most prevalent conditions in a defined American population. Mayo Clin Proc. 2013; 88(1): 56-67.

Centers for Disease Control and Prevention (USA): National ambulatory medical care survey: 2010 summary table. Atlanta, GA: CDC. Available at http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf. Accessed November 14, 2015.

National Institutes of Health Medline Plus (USA): Chronic pain: Symptoms, diagnosis, & treatment. Bethesda, MD: NIH, 2011. Available at https://www.nlm.nih.gov/medlineplus/magazine/issues/spring11/articles/spring11pg5-6.html. Accessed January 10, 2016.

Elliott AM, Smith BH, Penny KI, et al.: The epidemiology of chronic pain in the community. Lancet. 1999; 354(9186): 1248-1252.

Chou R, Turner JA, Devine EB, et al.: The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015; 162(4): 276-286.

Harris PA, Taylor R, Thielke R, et al.: Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2): 377-381.

Fink R: Pain assessment: The cornerstone to optimal pain management. Baylor Univ Med Cent Proc. 2000; 13(3): 236.

Weimer M, Gideonse N, Mauer K, et al.: Guideline for safe chronic opioid therapy prescribing for patients with chronic non-cancer pain. 2013. Available at http://www.ohsu.edu/gim/epiclinks/opioidresources/opioidguidelines.htm#. Accessed January 12, 2016.

Von Korff M, Saunders K, Ray GT, et al.: Defacto long-term opioid therapy for non-cancer pain. Clin J Pain. 2008; 24(6): 521-527.

Morasco BJ, Duckart JP, Carr TP, et al.: Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010; 151(3): 625-632.

Beehler GP, Rodrigues AE, Mercurio-Riley D, et al.: Primary care utilization among veterans with chronic musculoskeletal pain: A retrospective chart review. Pain Med. 2013; 14(7): 1021-1031.

Krein SL, Heisler M, Piette JD, et al.: The effect of chronic pain on diabetes patients’ self-management. Diabetes Care. 2005; 28(1): 65-70.

Butchart A, Kerr EA, Heisler M, et al.: Experience and management of chronic pain among patients with other complex chronic conditions. Clin J Pain. 2009; 25(4): 293-298.

Härter M, Baumeister H, Reuter K, et al.: Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom. 2007; 76(6): 354-360.

McWilliams LA, Cox BJ, Enns MW: Mood and anxiety disorders associated with chronic pain: An examination in a nationally representative sample. Pain. 2003; 106(1): 127-133.

Gureje O, Von Korff M, Simon GE, et al.: Persistent pain and well-being: A World Health Organization study in primary care. JAMA. 1998; 280(2): 147-151.

Jiang W, Glassman A, Krishnan R, et al.: Depression and ischemic heart disease: What have we learned so far and what must we do in the future? Am Heart J. 2005; 150(1): 54-78.

Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med. 2004; 66(6): 802-813.

American Heart Association (USA): Mental health and heart health. 2014. Available at http://www.heart.org/HEARTORG/GettingHealthy/StressManagement/HowDoesStressAffectYou/Mental-Health-and-Heart-Health_UCM_438853_Article.jsp#. Accessed December 29, 2015.

Regier DA, Farmer ME, Rae DS, et al.: Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990; 264(19): 2511-2518.

Kessler RC, Nelson CB, McGonagle KA, et al.: The epidemiology of co-occurring addictive and mental disorders:

Implications for prevention and service utilization. Am J Orthopsychiatry. 1996; 66(1): 17-31.

Grant BF, Stinson FS, Dawson DA, et al.: Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004; 61(8): 807-816.

Ives TJ, Chelminski PR, Hammett-Stabler CA, et al.: Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res. 2006; 6(1): 46.

Turk DC, Swanson KS, Gatchel RJ: Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain. 2008; 24(6): 497-508.

Krebs EE, Ramsey DC, Miloshoff JM, et al.: Primary care monitoring of long-term opioid therapy among veterans with chronic pain. Pain Med. 2011; 12(5): 740-746.

Pahuja D, Chadha P: Red flags within documentation for hospitalists. The Hospitalist. 2011. Available at http://www.the-hospitalist.org/article/red-flags-within-documentation-forhospitalists/?singlepage=1. Accessed December 18, 2015.

Wood DL: Documentation guidelines: Evolution, future direction, and compliance. Am J Med. 2001; 110(4): 332-334.

Gottschalk A, Flocke SA: Time spent in face-to-face patient care and work outside the examination room. Ann Family Med. 2005; 3(6): 488-493.

Chen MA, Hollenberg JP, Michelen W, et al.: Patient care outside of office visits: A primary care physician time study. J Gen Intern Med. 2011; 26(1): 58-63.

Tai-Seale M, McGuire TG, Zhang W: Time allocation in primary care office visits. Health Serv Res. 2007; 42(5): 1871-1894.

Chen LM, Farwell WR, Jha AK: Primary care visit duration and quality: Does good care take longer? Arch Intern Med. 2009; 169(20): 1866-1872.

Mechanic D, McAlpine DD, Rosenthal M: Are patients' office visits with physicians getting shorter? N Engl J Med. 2001; 344(3): 198-204.

Linzer M, Konrad TR, Douglas J, et al.: Managed care, time pressure, and physician job satisfaction: Results from the physician worklife study. J Gen Intern Med. 2000; 15(7): 441-450.

Gourlay DL, Heit HA, Almahrezi A: Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med. 2005; 6(2): 107-112.

Hwang CS, Turner LW, Kruszewski SP, et al.: Primary Care physicians' knowledge and attitudes regarding prescription opioid abuse and diversion. Clin J Pain. 2016; 32(4): 279-284.

Quill TE: Partnerships in patient care: A contractual approach. Ann Intern Med. 1983; 98(2): 228-234.

Fishman SM, Bandman TB, Edwards A, et al.: The opioid contract in the management of chronic pain. J Pain Symptom Manage. 1999; 18(1): 27-37.

Payne R, Anderson E, Arnold R, et al.: A rose by any other name: Pain contracts/agreements. Am J Bioeth. 2010; 10(11): 5-12.

Starrels JL, Wu B, Peyser D, et al.: It made my life a little easier: Primary care providers’ beliefs and attitudes about using opioid treatment agreements. J Opioid Manag. 2014; 10(2): 95-102.

Fagan MJ, Chen JT, Diaz JA, et al.: Do internal medicine residents find pain medication agreements useful? Clin J Pain. 2008; 24(1): 35-38.

Wiedemer NL, Harden PS, Arndt IO, et al.: The opioid renewal clinic: A primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007; 8(7): 573-584.

United States Drug Enforcement Administration: Drug scheduling. Available at http://www.dea.gov/druginfo/ds.shtml. Accessed November 14, 2015.

Bohnert AS, Valenstein M, Bair MJ, et al.: Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305(13): 1315-1321.

Gomes T, Mamdani MM, Dhalla IA, et al.: Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011; 171(7): 686-691.

Dunn KM, Saunders KW, Rutter CM, et al.: Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med. 2010; 152(2): 85-92.

Dowell D, Haegerich T, Chou R: CDC Guideline for prescribing opioids for chronic pain—United States, 2016. Atlanta, GA: Centers for Disease Control and Prevention, 2016. Available at http://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm#B1_down. Accessed May 23, 2016.

U.S. Food and Drug Administration: FDA News release. United States: FDA. 2013. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367726.htm. Accessed May 24, 2016.

U.S. Food and Drug Administration: Questions and answers: FDA. Silver Spring, MD: FDA, 2013. Available at http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm309742.htm. Accessed May 24, 2016.

Starrels JL, Becker WC, Alford DP, et al.: Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010; 152(11): 712-720.